CON
Concentra Group Holdings Parent, Inc.NYSEHealthcare$20.89-1.60%ClosedMarket Cap: $2.69B
As of 2026-04-06
Valuation
P/E (TTM)
16.15
PEG
—
P/B
6.76
P/S
1.25
EV/EBITDA
11.55
DCF Value
$55.19
FCF Yield
10.3%
Div Yield
1.2%
Margins & Returns
Gross Margin
28.3%
Operating Margin
96.5%
Net Margin
7.7%
ROE
46.6%
ROA
5.5%
ROIC
57.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $539.1M | 26.1% | $1.82B | $34.7M | $0.28 | $0.06 |
| FY 2025 | $2.16B | 28.3% | $2.09B | $172.8M | $1.30 | $0.25 |
| Q3 2025 | $572.8M | 29.2% | $94.5M | $48.3M | $0.37 | $0.06 |
| Q2 2025 | $550.8M | 29.3% | $89.5M | $44.6M | $0.34 | $0.06 |
| Q1 2025 | $500.8M | 28.7% | $80.3M | $38.9M | $0.31 | $0.06 |
| Q4 2024 | $465.0M | 25.8% | $59.1M | $21.5M | $0.17 | $0.06 |
| FY 2024 | $1.90B | 27.8% | $304.8M | $166.5M | $1.30 | $0.06 |
| Q3 2024 | $489.6M | 35.7% | $86.2M | $44.3M | $0.35 | — |
| Q2 2024 | $477.9M | 25.3% | $83.9M | $51.7M | $0.41 | — |
| Q1 2024 | $467.6M | 27.9% | $75.5M | $49.0M | $0.39 | — |
| Q4 2023 | $440.7M | 24.9% | $48.9M | $-24.5M | $-0.19 | — |
| FY 2023 | $1.84B | 27.9% | $287.6M | $179.9M | $1.42 | — |